Screening blood donations for viral genomes: Multicenter study of real- time simulation using pooled samples on the model of hepatitis C virus RNA detection

Transfusion

Volumn 38, Issue 10, 1998, Pages 915-923

  Lefrere J J ^a   Coste, J ^b   Defer, C ^c   Mercier, B ^d   Ferec C ^d   Loiseau, P ^e   Portelette, E ^e   Mariotti, M ^a   Lerable, J ^a   Rouger, P ^a   Pawlotsky, J M ^f  

^a INSTITUT NATIONAL DE LA TRANSFUSION SANGUINE   (France)

^b Etablissement de Transfus Sanguine   (France)

^c Nord Pas de Calais   (France)

^d Centre de Biogénétique   (France)

^e ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^f HENRI MONDOR HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD TRANSFUSION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; VIRUS DETECTION; VIRUS GENOME;

EID: 0031697024     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1998.381098440855.x     Document Type: Article

References (14)

1. Schreiber GB, Busch MP, Kleinman SH, et al. The risk of transfusion-transmitted viral infections. N Engl J Med 1996;334:1685-90.
2. Linden JV. Error contributes to the risk of transmissible disease (letter). Transfusion 1994;34:1016.
3. Vernelen K, Claeys H, Verhaert H, et al. Significance of NS3 and NS5 antigens in screening for HCV antibody (letter). Lancet 1994;343:853.
4. Widell A, Elmud H, Persson MH, Jonsson M. Transmission of hepatitis C via both erythrocyte and platelet transfusions from a single donor in serological window-phase of hepatitis C. Vox Sang 1996;71:55-7.
5. Rogers PM, Saldanha J, Allain JP. Report of EPFA/NIBSC Workshop "Nucleic Acid Amplification Test (NAT) for the detection of blood-borne viruses" held on 31 October 1996 in Amsterdam, the Netherlands. Vox Sang 1997;72:199-206.
6. Improvement of hepatitis C virus RNA polymerase chain reaction through a multicentre quality control study. French Study Group for the Standardization of Hepatitis C Virus PCR. J Virol Methods 1994;49:79-88.
7. Zaaijer HL, Cuypers HTM, Reesink HW, et al. Reliability of polymerase chain reaction for detection of hepatitis C virus. Lancet 1993;341:722-4.
8. Damen M, Cuypers HT, Zaaijer HL, et al. International collaborative study on the second Eurohep HCV-RNA reference panel. J Virol Methods 1996;58:175-85.
9. Hawkins A, Davidson F, Simons P. Comparison of plasma virus loads among individuals infected with hepatitis C virus (HCV) genotypes 1, 2 and 3 by quantiplex HCV RNA assay versions 1 and 2, Roche Monitor assay, and an in-house limiting dilution method. J Clin Microbiol 1997;35:187-92.
10. Pawlotsky JM, Bastie A, Lonjon I, et al. What technique should be used for routine detection and quantification of HBV DNA in clinical samples? J Virol Methods 1997;65:245-53.
11. Wolfe L, Tamatsukuri S, Sayada C, Ryff IC. Detection of HCVRNA in serum using a single-tube, single enzyme PCR in combination with a colorimetric microwell assay. In: Hepatitis C virus: new diagnostic tools. Groupe français d'études moléculaires des hépatites, GEMHEP. Montrouge, France: John Libbey Eurotext, 1994:83-94.
12. Kessler HH, Dragon EA, Pierer K, et al. Performance of the automated Cobas Amplicor system for the detection of hepatitis C virus RNA. Clin Diagn Virol 1997;7:139-45.
13. Kolberg J, Sanchez-Pescardor R, Detmer J, et al. Branched DNA (bDNA) quantitation of hepatitis C viral RNA in patient sera. In: Hepatitis C virus: new diagnostic tools. Groupe français d'étude moléculaire des hépatites, GEMHEP. Montrouge, France: John Libbey Eurotext, 1994:71-82.
14. Stuyver L. HCV genotypes and genotyping methods. In: Hepatitis C virus: New diagnostic tools. Groupe français d'étude moléculaire des hépatites, GEMHEP. Montrouge, France: John Libbey Eurotext, 1994:39-48.